Resource Hub: Cancer Types, Protocols, Metabolic & Precision Oncology Library

⚠ Medical Disclaimer: This page is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. All protocols and drug information discussed here should be reviewed with a qualified physician before implementation. Repurposed drugs discussed here are not approved by regulatory agencies (FDA, EMA, etc.) for the treatment of cancer unless otherwise stated. Evidence levels are indicated throughout. This page also contains affiliate links (see disclosure at the bottom).

Smart Cancer | OneDayMD Editorial Team · Medically reviewed by Dr Frank Yap, MD · Last Updated: August 2026

The Complete Integrative Oncology & Precision Oncology Resource Hub — 2026 Edition

An evidence-informed guide covering repurposed drugs, metabolic cancer theory, diet, nutraceuticals, prevention, and cancer-specific treatment playbooks. Built for patients, caregivers, clinicians, and researchers navigating beyond standard-of-care.

📞 Find a Doctor — The Wellness Company (use code ONEDAYMD)

🔎 Quick Answer

This directory is Smart Cancer's central navigation hub for the metabolic and precision oncology content published across the Cancer Advisor network (SmartCancer.org, cancer.aestheticsadvisor.com, OneDayMD.com). It indexes: (1) cancer types by body system, (2) official ASCO/NCCN/ESMO treatment guidelines, (3) the metabolic theory of cancer and Dr Paul Marik's Five-Axis Metabolic Trap, (4) an evidence-tiered reference table of repurposed drugs (fenbendazole, ivermectin, mebendazole, metformin, and others), (5) nutraceuticals with anticancer evidence, (6) cancer-specific treatment playbooks, (7) prevention frameworks (ROOTS, I-PREVENT), and (8) a 760+ patient case-series compilation. Regulatory note: in May 2026, ASCO issued a formal Clinical Notice recommending against ivermectin and fenbendazole for cancer treatment outside of a registered clinical trial — see the callout below before reviewing the repurposed-drug sections.

Last Updated: August 2026 | About Us

✓ What Sets The Cancer Advisor Apart

✓ Evidence-Tiered Framework

All content is graded by CEBM evidence level (Tier 1–4), distinguishing RCT-grade evidence from case reports and expert opinion.

✓ Independent & Unsponsored

No pharmaceutical sponsorship. Content covers both conventional and integrative approaches without institutional bias.

✓ Southeast Asian & Global Relevance

Regional context for Malaysia, Singapore, and broader Asia-Pacific, where access to novel therapies and pricing dynamics differ significantly from Western markets.

✓ Integrates Dr Paul Marik's Library

The only platform synthesising Dr Marik's Cancer & Metabolic Library with Cancer Advisor's 760+ case series database in one navigable hub.

✓ Patient-First Framing

Complex science translated into actionable, decision-ready information for patients, caregivers, and health-conscious individuals — not just clinicians.

✓ Living Document

Updated continuously as research evolves, including regulatory developments such as ASCO's May 2026 Clinical Notice. Over 175 articles published in 2026 alone across the Cancer Advisor network.

Understanding Cancer Through Two Complementary Frameworks

The Genetic Framework (Dominant Paradigm)

Treats cancer as a disease of somatic mutations driving uncontrolled cell division. Underpins conventional oncology: surgery, chemotherapy, radiotherapy, targeted therapy, and immunotherapy. Molecular profiling and biomarker-directed treatments (KRAS, EGFR, BRCA, PD-L1) are products of this framework. Our curated directory of ASCO, NCCN, and ESMO Clinical Guidelines provides direct access to these established institutional protocols.

⚡ The Metabolic Framework (Emerging)

Frames cancer as a metabolic disease driven by mitochondrial dysfunction and aberrant energy metabolism (the Warburg Effect). Championed by researchers including Thomas Seyfried, Paul Marik, and the FLCCC Alliance. Opens the door to repurposed drugs, ketogenic diet, fasting, and metabolic interventions.

Key concept: Cancer cells preferentially ferment glucose to lactate even in the presence of oxygen (aerobic glycolysis / Warburg Effect). This metabolic vulnerability is a therapeutic target accessible with repurposed drugs, dietary modification, and nutraceuticals. Both frameworks are complementary, not mutually exclusive.

Key reading: Cancer Is a Metabolic Disease (Dr Paul Marik) | Expert Explains Cancer May Be a Metabolic Disease | Thomas Seyfried Protocol

Cancer Types by Body System — Complete Directory

Click any cancer type for detailed information. Links open to Cancer Advisor resources where available, otherwise to American Cancer Society reference pages.

♂ Top 3 Cancers in Men

1. Lung Cancer — leading cause of cancer deaths; primarily linked to smoking
2. Prostate Cancer — most common cancer in men; detected via PSA screening
3. Colorectal Cancer — risk factors include age, diet, family history

♀ Top 3 Cancers in Women

1. Breast Cancer — most frequently diagnosed cancer in women
2. Lung Cancer — significant concern; smoking a primary risk factor
3. Colorectal Cancer — colonoscopy screening plays a crucial role

⚕ Clinical Practice Guidelines (For Healthcare Professionals)

To safely navigate beyond standard-of-care options, clinicians and patients must first establish a rock-solid understanding of official therapeutic benchmarks. These consensus-driven frameworks outline standard staging workflows, first-line through late-line conventional regimens, and toxicity monitoring.

1. ASCO Clinical Practice Guidelines (American Society of Clinical Oncology) — The global gold standard for evidence-based clinical recommendations. ASCO provides disease-oriented guidance across solid tumors and hematologic malignancies, as well as modality-specific guidelines (e.g., molecular testing, ctDNA tracking, and immune-checkpoint inhibitor toxicity management). Their living guideline updates ensure changes in survival data translate rapidly to clinical practice — including, as of May 2026, formal cautionary notices on unproven repurposed-drug protocols (see the regulatory callout above).

2. NCCN Guidelines by Cancer Type (National Comprehensive Cancer Network) — Highly detailed, algorithm-driven sequential workflows for more than 30 distinct cancer types. Widely utilized by oncologists and insurance bodies to define step-by-step treatment pathways alongside dedicated supportive care blocks.

3. ESMO Clinical Practice Guidelines (European Society for Medical Oncology) — The primary clinical practice recommendations for Europe, with Living Guidelines for fast-evolving disease profiles and Pan-Asian Guidelines Adaptations (PAGA) for regional genetic and pricing differences in the Asia-Pacific.

Integration Note: When designing a personalized integrative strategy, these standard guidelines should be reviewed side-by-side with our metabolic and off-label references to uncover opportunities for synergy — such as using metabolic therapies to mitigate chemotherapy toxicities or enhance treatment sensitivity.

The Metabolic Foundations of Cancer

Cancer's metabolic dependencies create targetable vulnerabilities beyond what conventional genetics-based precision oncology addresses. Understanding these foundations is prerequisite to designing a rational integrative strategy.

Topic	Description	Source
Cancer Stem Cells	The role of cancer stem cells in treatment resistance, recurrence, and metastasis	Dr Paul Marik
Cancer Immunity & TME	How the tumor microenvironment suppresses immune response and how to reverse it	Dr Paul Marik
Reprogramming the TME	Repurposed drugs and nutraceuticals that remodel immune suppression in tumors	Dr Paul Marik
Repurposed Drugs: New Frontier ⭐	Foundational overview of repurposed drugs and nutraceuticals as cancer adjuncts	Dr Paul Marik
Glycolytic Enzyme Targeting	Targeting HK2, GLUT1, LDHA and other glycolytic enzymes with drugs & nutraceuticals	Dr Paul Marik
Mitochondrial–Stem Cell Connection	Targeting the mitochondrial-stem cell axis to eliminate therapy-resistant cancer cells	Cancer Advisor

♞ Building the Metabolic Strategy: Dr Paul Marik's Five-Axis Model

Dr Paul Marik's Five-Axis Metabolic Trap argues that attacking cancer on five simultaneous axes — glycolysis, glutamine, fatty acid oxidation, immune/TME reprogramming, and cancer stem cells — closes the escape routes that drive treatment resistance. Ivermectin is specifically identified as a "network amplifier" within this model, with demonstrated preclinical activity across multiple axes simultaneously — though, per the ASCO notice above, this has not yet translated into proven clinical benefit in humans.

AXIS 1 Glycolysis/Glucose · AXIS 2 Glutamine/OXPHOS · AXIS 3 Fatty Acid Oxidation · AXIS 4 Immune/TME Reprogramming · AXIS 5 Cancer Stem Cell Suppression

Article	Priority
The Metabolic Trap: The Five-Axis Metabolic Pressure Model	⭐ Essential
Ivermectin: A Network Amplifier in the Metabolic Cancer Trap	⭐ Essential
To Cycle or Not to Cycle: Rethinking Doxycycline and Mebendazole	⭐ Essential
Perioperative Drugs to Reduce Metastases	⭐ Essential
Press Pulse Protocol 2.0 (2026): Complete Immunometabolic Framework	Cancer Advisor
The 3/4 Day Metabolic Pulse Framework: Pharmacological Rationale	Cancer Advisor
Integrating Fenbendazole, Ivermectin & Mebendazole: The 2026 Protocol	Cancer Advisor
The Integrated Metabolic Cancer Framework 2026	Cancer Advisor

⚡ The Warburg Revolution

Our multi-part Warburg Effect series (six parts, June 2026) and the standalone "Warburg Effect Revisited in 2026" article have been consolidated and superseded by a single, continuously updated pillar guide. We recommend starting there rather than the original serialized articles:

⭐ The Warburg Effect in Cancer: The Definitive 2026 Guide to Aerobic Glycolysis, Molecular Drivers, and Metabolic Therapy

Covers the molecular machinery (c-Myc, GLUT1, Hexokinase-2), the PI3K/AKT/mTOR master switch, therapeutic strategies, nutraceuticals that target the Warburg network, a systems-level integration view, the insulin/glucose connection, and Jane McLelland's critique of metabolic cancer theory — all in one place. Consolidates and supersedes the prior six-part series and the "Warburg Effect Revisited" standalone article.

Diet & Metabolism in Cancer

Diet is the foundation of the metabolic approach to cancer. Restricting glucose availability through ketogenic, low-carbohydrate, or time-restricted eating approaches can starve cancer cells while supporting healthy tissue.

Article	Source
Why Diet is the Foundation of the Metabolic Approach to Cancer ⭐	Dr Paul Marik
Dietary Interventions in Cancer (Part 1)	Dr Paul Marik
What to Eat When You Have Cancer (Part 2)	Dr Paul Marik
Role of Fasting and Fasting-Mimicking Diets (FMDs) During Chemotherapy	Dr Paul Marik
Insulin Resistance: The Silent Engine of Cancer Growth	Dr Paul Marik
Eat These Foods to Starve Cancer Cells to Death (2026 Update)	Cancer Advisor
Pancreatic Cancer and Insulin Resistance: The Overlooked Connection	Cancer Advisor
I-TREAT Cancer Protocol: Diet and Lifestyle Guide For Cancer	OneDayMD

Repurposed Drugs in Cancer — Evidence Reference Table

Evidence Note: Most evidence is CEBM Level 3–5 (observational, case reports, preclinical). None of the drugs below are approved as standalone cancer treatments unless specifically noted. Always use under physician supervision. Ivermectin and fenbendazole specifically are the subject of ASCO's May 2026 Clinical Notice recommending against cancer use outside a registered clinical trial (see callout near the top of this page).

Drug	Original Indication	Proposed Anticancer Mechanisms	Key Resources
Fenbendazole	Veterinary anthelmintic	Microtubule disruption, glycolysis inhibition (HK2), p53 activation, autophagy induction	Joe Tippens Protocol \| Science Review
Ivermectin	Human/veterinary antiparasitic	P-glycoprotein inhibition, WNT/β-catenin inhibition, SHP2 inhibition, TME reprogramming, cancer stem cell suppression	Marik: IVM & Cancer \| 2026 Review
Mebendazole	Human anthelmintic	Multi-axis metabolic inhibition, tubulin disruption, anti-angiogenic, BCL-2 inhibition	Marik: MBZ \| Dosing ⭐
Metformin	Type 2 diabetes	AMPK activation, mTOR inhibition, Complex I inhibition, anti-proliferative, insulin sensitisation	Marik: Metformin ⭐
Doxycycline	Antibiotic	Mitochondrial protein synthesis inhibition, cancer stem cell targeting, anti-angiogenic	Marik: Doxycycline
Melatonin	Sleep / circadian rhythm	Antioxidant, immune modulation, anti-proliferative, apoptosis induction, anti-angiogenic	Marik: Cancer Hates Darkness
Statins	Cholesterol / cardiovascular	Mevalonate pathway disruption, anti-proliferative, pro-apoptotic, anti-inflammatory	Top 17 Alt Treatments
Aspirin / Diclofenac	NSAID / anti-inflammatory	COX-2 inhibition, NF-κB suppression, prostaglandin E2 reduction, anti-metastatic	Cancer Advisor Guide
Low Dose Naltrexone	Opioid antagonist	Immune modulation, TLR4 antagonism, endorphin upregulation, OGF pathway activation	Marik Library (in development)
Itraconazole	Antifungal	Hedgehog pathway inhibition, anti-angiogenic, VEGFR2 blockade, P-gp inhibition	Marik Library (in development)
Methylene Blue	Methemoglobinemia / psychiatric	Mitochondrial electron transport chain support, oxidative stress in cancer cells, photodynamic effects	Methylene Blue Guide
DMSO	Industrial solvent / anti-inflammatory	Cell differentiation induction, carrier for combination therapies, anti-proliferative	DMSO for Cancer (3-Part Series)

Dr William Makis Protocols (2026)

Dr William Makis (McGill Medicine; 110+ peer-reviewed publications) has been publicly documenting antiparasitic cancer protocols and patient outcomes via Substack and X (@MakisMD) since 2023. His approach centres on high-dose ivermectin combined with benzimidazoles (fenbendazole, mebendazole).

⚕ Licensure Status (updated August 2026): Mr Makis's Alberta practice permit lapsed in 2019 for non-renewal. Following a 2025 complaint, the College of Physicians and Surgeons of Alberta (CPSA) obtained an interim injunction in August 2025 restricting him from representing himself as a licensed physician, from using the titles "doctor," "Dr.," or "oncologist" in connection with health services, and from providing cancer advice or consultations to the public. His bid to stay that injunction was denied by the Alberta Court of Appeal in January 2026. On March 4, 2026, the Alberta Court of King's Bench found him in contempt of the order and converted it into a permanent injunction on the same terms. A further appeal was dismissed by the Alberta Court of Appeal on June 17, 2026. He is not currently licensed to practise medicine or provide cancer advice/consultations in Alberta, and should not be represented or relied upon as a treating physician. The protocol content below is retained for its historical and mechanistic reference value and because it is widely discussed by patients; it should be read as a compilation of publicly documented, patient-reported dosing patterns rather than physician guidance, and evaluated alongside ASCO's May 2026 Clinical Notice above. All protocols require supervision from a properly licensed physician.

Dr William Makis Ivermectin Protocol 2026: Complete Guide
Dr William Makis's Recommended Ivermectin Dosages for Cancer (2026)
Ivermectin and Fenbendazole: Treating Turbo Cancer — Dr William Makis

Nutraceuticals & Anti-Cancer Supplements

Nutraceutical	Key Anticancer Mechanisms	Evidence Level	Resource
Vitamin D3	Anti-proliferative, pro-apoptotic, immune modulation, VDR signalling	Tier 2 — Observational + RCTs	Marik
Curcumin (Turmeric)	NF-κB inhibition, anti-inflammatory, pro-apoptotic, anti-angiogenic	Tier 2 — Preclinical + Observational	Guide
EGCG (Green Tea)	VEGF inhibition, PI3K/AKT inhibition, cancer stem cell suppression	Tier 2 — Preclinical + Observational	Marik
Berberine	AMPK activation, mTOR inhibition — "natural metformin"	Tier 2 — Preclinical + some RCTs	Marik
Sulforaphane	Nrf2 activation, Phase II detoxification, histone deacetylase inhibition	Tier 2 — Preclinical	Marik
Omega-3 Fatty Acids	Anti-inflammatory (PGE2 suppression), anti-metastatic, immune modulation	Tier 2 — Observational + RCTs	Guide
Modified Citrus Pectin	Galectin-3 inhibition, anti-metastatic, immune-enhancing	Tier 2 — Preclinical + pilot	Marik
Molecular Hydrogen	Selective antioxidant, anti-inflammatory, mitochondrial protection	Tier 3 — Emerging RCTs	Guide

➡ Read Full Anti-Cancer Supplement Review (2026 Update)

Cancer-Specific Playbooks

Cancer-specific playbooks apply the metabolic and integrative framework to individual cancer types. Dr Paul Marik's series provides condition-specific strategic guidance; the Cancer Advisor deep dives provide patient-level outcome data.

Dr Paul Marik Playbooks

Prostate Cancer (Part 1)
Prostate Cancer (Part 2 — Neuroendocrine)
Breast Cancer (in development)
Colorectal Cancer (in development)
Pancreatic Cancer (in development)
Follicular Lymphoma (in development)
Neuroendocrine Tumors Parts 1 & 2 (in development)
Thyroid, Uterine, HPV-Oral Cancers (in development)

Cancer Advisor Deep Dives

Prostate Cancer
Pancreatic Cancer
Metastatic Colorectal Cancer
Cold vs Hot Tumors & Immunotherapy
MSI-H & Immunotherapy Response
Glioblastoma & Repurposed Drugs
Oncolytic Virotherapy in Colorectal
CAR-T vs CAR-NK Cell Therapy

Prevention: ROOTS Protocol & I-PREVENT

ROOTS Protocol — Dr Paul Marik

A systemic cancer prevention framework addressing root metabolic and lifestyle drivers of cancer initiation and promotion.
• What the Public Is Not Told About Cancer Prevention
• The ROOTS Protocols ⭐
• Preventing Breast Cancer
• Preventing Colorectal Cancer
• Preventing Melanoma (Parts 1 & 2)
• Preventing Prostate Cancer
• PSA Screening: What You Need to Know
(Published progressively on Marik Substack)

✅ I-PREVENT Protocol — OneDayMD

Evidence-based cancer prevention framework covering diet, lifestyle, supplements, and actionable habits.
• I-PREVENT CANCER Protocol 2026
• Evidence-Based Cancer Prevention Guide
• Best Supplements: Vit D3, K2, Omega-3, Turmeric, Vit C, Mg, H₂, Zinc, Garlic
• Lifestyle: smoking cessation, weight management, exercise, stress reduction
• Diet: plant-based, Mediterranean, avoid processed foods
• The Cancer Prevention Habit Hack (VILPA)

Treatment Protocols Index

Protocol	Core Components	Source
Fenbendazole Joe Tippens Protocol	Fenbendazole 222mg + Vitamin E succinate + Curcumin + CBD (3 days on / 4 days off)	Joe Tippens / Cancer Advisor 2026
Cancer Stem Cell Protocol	Ivermectin + Fenbendazole + Mebendazole combination targeting cancer stem cells	OneDayMD 2024
Integrated Metabolic Cancer Protocol 2026	Full five-axis protocol: IVM + MBZ + FBZ + Metformin + nutraceuticals + diet + cycling	Cancer Advisor 2026
Press Pulse Protocol 2.0 (2026)	Seyfried-inspired: ketogenic diet (press) + metabolic pulse (chemotherapy/repurposed drugs)	Cancer Advisor 2026
3/4 Day Metabolic Pulse Framework	Evidence-based cycling regimen for repurposed drugs to prevent resistance	Cancer Advisor 2026
MTD vs Metronomic Chemotherapy	Comparing high-dose vs low-dose metronomic chemo scheduling and integrative layering	Cancer Advisor 2026
Thomas Seyfried Protocol	Water fasting + ketogenic diet + hyperbaric oxygen + press-pulse metabolic therapy	OneDayMD / Seyfried
IMA: Repurposed Drugs & Metabolic Interventions	Independent Medical Alliance evidence synthesis and clinical guidance	FLCCC / IMA

Case Series by Cancer Type — 760+ Patient Records

Evidence Level: All case reports represent CEBM Level 4–5 evidence (case reports, expert opinion). This compilation is hypothesis-generating only. Testimonials are uncontrolled anecdotal accounts shared voluntarily by patients — not a substitute for controlled trial data.

On the largest single dataset: The most-cited real-world cohort behind these figures, Hulscher et al. (2026, n=197), is currently under a formal Expression of Concern from its publishing journal and carries an unresolved author conflict of interest (a Wellness Company affiliation). It should not be treated as confirmatory evidence, and is included here for transparency about what the "case series" total is built from, not as a validated outcome study.

⭐ Fenbendazole, Ivermectin, and Mebendazole in Cancer: A 750+ Case Anecdotal Signal Analysis and Strategic Evidence Review (2026)

Our flagship synthesis: a systematic compilation of 760+ patient-reported outcomes across 31 cancer subtypes, cross-referenced against ASCO's May 2026 Clinical Notice and the Hulscher Expression of Concern. Start here for the most current, most heavily cross-checked version of this dataset.

Breast Cancer (120+ cases) · Prostate Cancer (120+ cases) · Pancreatic Cancer (23 cases) · Colorectal Cancer (23 cases) · Lung Cancer (18 cases) · Head & Neck Cancer (10 cases) · Kidney Cancer (10 cases) · Lymphoma (8 cases) · Melanoma / Skin Cancer (8 cases) · Endometrial Cancer (6 cases) · Uterine Cancer (6 cases) · Esophageal & Stomach Cancer (6 cases) · Ovarian Cancer (4 cases) · Sarcoma (3 cases) · Liver Cancer (HCC) (3 cases) · Multiple Myeloma (2 cases) · Leukemia (AML & CLL) (2 cases) · Brain Cancer / Glioblastoma (120+ cases) · Thymus Cancer · Stage IV Urothelial → Remission ⭐

➡ Browse the Full 760+ Ivermectin and Mebendazole Patient Case Series Compilation

Popular Guides — Start Here

I-PREVENT CANCER Protocol

• Diet & Cancer Prevention (plant-based, Mediterranean)
• Lifestyle: smoking cessation, healthy weight, exercise, stress
• Best Anti-Cancer Supplements: Vit D3, K2, Omega-3, Turmeric, Vit C, Magnesium, Molecular Hydrogen, Zinc, Garlic
• Other: quality sleep, avoid toxins, infections, carcinogens

I-TREAT Cancer Protocol

• Causes of Cancer & the ACS 2022 Guideline for Cancer Survivors
• The Metabolic Approach to Treating Cancer
• Body Weight and Physical Activity
• Best Anti-Cancer Supplements (Evidence-based): Vit D3, Turmeric, Magnesium & Molecular Hydrogen, Whole Food Vit C, EGCG, Melatonin, Omega-3

Top 17 Alternative Cancer Treatments That Work — Evidence Based

Avoid Ultra Processed Foods & Sugar • Vitamin D3 & Omega-3 • Fenbendazole / Mebendazole / Albendazole • Turmeric (Curcumin) • Vitamin C • Magnesium & Molecular Hydrogen • Ivermectin • Metformin • Melatonin • EGCG • Mistletoe • Aspirin & Celecoxib • Statins • Hyperthermia • Gerson Therapy • HBOT • Stress, Sleep & Sunshine

Conventional Oncology Through a Metabolic Lens

• Overview of Chemotherapy and Metronomic Dosing (Dr Marik)
• Integration of Metronomic Chemotherapy with Repurposed Drugs ⭐ (Dr Marik)
• Bridging the Gap: Repurposed Drugs Between Conventional Therapy Cycles (Dr Marik)
• The Chemotherapy Decision Nobody Explains: MTD vs Metronomic Protocols
• New Cancer Treatment Breakthroughs 2026: Immunotherapy & Beyond
• The Abscopal Effect: How Radiation Therapy Can Trigger Systemic Immune Response
• CyberKnife Radiotherapy: Precision Cancer Treatment Explained
• Cancer Biomarker Testing Guide: CEA, CA-125, PSA, and Beyond

🤖 Using AI to Personalise Your Cancer Research

AI tools can help you synthesise the information across this library and personalise it to your specific cancer type, mutation profile, treatment history, and goals. None of these tools replace a physician — use their output as a starting point for a conversation with your oncology team.

🤖 Claude (claude.ai)

"Upload your pathology report, scan results, or blood work. Ask: 'Based on my KRAS G12D mutation and Stage 3 pancreatic cancer, which repurposed drugs from the Marik protocol are most relevant to my situation, and what does ASCO's current guidance say about them?'"

💬 ChatGPT

"Use the Browse function to fetch and summarise specific articles from this library. Ask: 'Summarise the five-axis metabolic trap for a patient with triple-negative breast cancer.'"

🔍 Perplexity AI

"Ideal for sourced answers. Ask: 'What is the current evidence for ivermectin in colorectal cancer, and what has ASCO said about it in 2026? Reference Dr Paul Marik and Cancer Advisor sources.'"

✨ Gemini

"Upload your medical documents directly. Ask: 'Based on my oncologist's report, what questions should I ask about integrative metabolic therapy?'"

Important: AI tools synthesise and summarise; they do not replace physician consultation. Use AI outputs as conversation starters with your oncologist or integrative medicine physician.

Resource Guides & Directories

Resource	What You'll Find
Find Oncologists & Integrative Cancer Clinics	Directory of integrative oncologists and cancer treatment centres globally
Cancer Types by System	Complete guide to cancer by organ system and biology
Integrative Oncology Treatment Directory	Comprehensive listing of integrative cancer treatment modalities and resources
Cancer Research: Natural Alternatives	Curated research database on natural and complementary cancer approaches
The Immunotherapy Revolution Series	Multi-part deep dive into checkpoint inhibitors, CAR-T, and cancer immunotherapy
The Wellness Company (TWC) — Find a Doctor	Access to integrative medicine physicians. Use code ONEDAYMD for referral discount.

❓ Frequently Asked Questions

What kind of information can I find on The Cancer Advisor?

You'll find detailed, unbiased articles covering conventional cancer treatments, emerging therapies like fenbendazole protocols, drug information, dosage guidelines, potential side effects, and safety precautions. The site also covers metabolic cancer theory, repurposed drugs, nutraceuticals, prevention frameworks, and a 760+ patient case-series compilation across 31 cancer subtypes.

What has changed in the regulatory landscape for repurposed antiparasitic drugs in 2026?

In May 2026, ASCO issued a formal Clinical Notice recommending against using ivermectin or fenbendazole for cancer treatment — including as an adjunct to conventional therapy — outside a registered clinical trial, citing the absence of robust peer-reviewed human evidence and a real risk of toxicity and drug interactions. A small number of early-phase human trials (a Phase I/II ivermectin combination trial and the Phase II ICONIC trial) are underway, with results not expected before late 2027. Separately, the largest published real-world cohort behind many "case series" claims (Hulscher et al., n=197) is under a formal Expression of Concern with an unresolved conflict of interest.

Is Dr. William Makis a licensed physician?

No. His Alberta practice permit lapsed in 2019, and a court-ordered permanent injunction (Alberta Court of King's Bench, March 2026, upheld on appeal in June 2026) currently bars him from representing himself as a licensed doctor, using the title "Dr." or "oncologist" in connection with health services, or providing cancer advice or consultations to the public. His protocols are covered on this site for their historical and mechanistic reference value, not as physician-supervised guidance.

What is fenbendazole, and why is it featured here?

Fenbendazole is an animal deworming drug that recent studies and anecdotal reports suggest may have anticancer properties via microtubule disruption, glycolysis inhibition (HK2), p53 activation, and autophagy induction. The Joe Tippens Protocol (fenbendazole 222mg, 3 days on / 4 days off, with Vitamin E succinate, curcumin, and CBD) popularized its use after Joe Tippens credited it, alongside a concurrent Keytruda (pembrolizumab) immunotherapy trial he was enrolled in, with his 2017 remission from metastatic small-cell lung cancer — a confound that makes fenbendazole's individual contribution impossible to isolate. As of 2026, he remains cancer-free for over 8 years. Fenbendazole has no regulatory approval for human cancer treatment, and ASCO's May 2026 Clinical Notice recommends against its use outside a clinical trial. Evidence remains primarily preclinical and anecdotal. Always consult a physician.

What is the metabolic theory of cancer and the five-axis model?

The metabolic theory, championed by Thomas Seyfried and Paul Marik, proposes cancer is fundamentally a metabolic disease driven by mitochondrial dysfunction and the Warburg Effect (aerobic glycolysis). Dr Marik's five-axis metabolic trap addresses cancer through five simultaneous pressure points: (1) glucose/glycolysis inhibition, (2) glutamine pathway targeting, (3) fatty acid oxidation disruption, (4) immune/TME reprogramming, and (5) cancer stem cell suppression. Ivermectin is identified as a "network amplifier" acting across multiple axes simultaneously in preclinical models.

How reliable is the information on this site?

The Cancer Advisor is committed to independent, evidence-based, consumer-focused health information. All content is graded using CEBM evidence tiers and is based on current research, expert analyses, and over 30 years of combined healthcare experience. Evidence limitations, retractions, and regulatory notices are disclosed where relevant. However, this site does not replace professional medical advice.

What nutraceuticals have the strongest anticancer evidence?

Vitamin D3, Curcumin, EGCG (Green Tea Extract), Omega-3 Fatty Acids, Melatonin, Berberine, Sulforaphane, Modified Citrus Pectin, Magnesium, and Molecular Hydrogen have the broadest evidence base. Each has a different evidence tier and mechanism of action. See the full supplement review for dose, evidence level, and cancer-type relevance.

Can I use this site to self-diagnose or self-treat cancer?

No. This site is designed to inform and empower you with knowledge but is not a substitute for professional diagnosis or treatment. Always consult qualified healthcare professionals for diagnosis, treatment plans, and monitoring. If you have stage 4 cancer, do not delay or abandon conventional treatment without physician guidance.

What is the ROOTS cancer prevention protocol?

The ROOTS protocol is Dr Paul Marik's evidence-informed framework for cancer prevention, addressing root metabolic and lifestyle drivers of cancer initiation. It covers diet, physical activity, metabolic health, targeted supplementation, and cancer-specific prevention guidance for breast, colorectal, melanoma, and prostate cancers.

How do I find trusted oncologists and integrative cancer physicians?

You can use The Cancer Advisor's Find Oncologists directory. The Wellness Company (TWC) also provides access to integrative medicine physicians — visit TWC Acute Care and use code ONEDAYMD for a referral discount.

Ready to Go Deeper?

Explore the full Cancer Advisor site, browse case series by cancer type, or contact us for collaboration and enquiries. If you have stage 4 cancer, do not lose hope — your story could be an inspiring success.

Browse by Topic Label:
fenbendazole ivermectin repurposed drugs metabolic health colorectal cancer prostate cancer lung cancer diet fasting keto diet NK cells colonoscopy pharma

KRAS · EGFR · BRCA · PD-L1 · ASCO · NCCN · ESMO · immunotherapy · precision oncology · metabolic oncology

Affiliate Disclosure: This page contains affiliate links to The Wellness Company (referral code ONEDAYMD). If you make a purchase or booking through these links, Smart Cancer / OneDayMD may earn a commission at no additional cost to you. This does not influence our evidence grading or editorial recommendations.

Smart Cancer | OneDayMD Editorial Team · Medically reviewed by Dr Frank Yap, MD · Last Updated: August 2026 · About Us · Privacy Policy

This page is a living document updated continuously as new research and articles are published across the Cancer Advisor network. Content is for educational purposes only and is not medical advice. © 2020–2026 OneDayMD.com. All Rights Reserved.